Dysregulation in the expression and/or activity of these enzymes could also have pathological consequences, and indeed overexpression of NEU3 has been linked to inflammatory diseases such as intestinal inflammation and colitis48, and aberrant expression of both NEU349 and ARSI50 in tumors has been linked to cancer progression. Here, NEU3 is linked to cancer.